Early warning systems (EWSs) for chikungunya, dengue, malaria, yellow fever, and Zika outbreaks: What is the evidence? A scoping review.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 16 9 2021
pubmed: 17 9 2021
medline: 15 12 2021
Statut: epublish

Résumé

Early warning systems (EWSs) are of increasing importance in the context of outbreak-prone diseases such as chikungunya, dengue, malaria, yellow fever, and Zika. A scoping review has been undertaken for all 5 diseases to summarize existing evidence of EWS tools in terms of their structural and statistical designs, feasibility of integration and implementation into national surveillance programs, and the users' perspective of their applications. Data were extracted from Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Latin American and Caribbean Health Sciences Literature (LILACS), PubMed, Web of Science, and WHO Library Database (WHOLIS) databases until August 2019. Included were studies reporting on (a) experiences with existing EWS, including implemented tools; and (b) the development or implementation of EWS in a particular setting. No restrictions were applied regarding year of publication, language or geographical area. Through the first screening, 11,710 documents for dengue, 2,757 for Zika, 2,706 for chikungunya, 24,611 for malaria, and 4,963 for yellow fever were identified. After applying the selection criteria, a total of 37 studies were included in this review. Key findings were the following: (1) a large number of studies showed the quality performance of their prediction models but except for dengue outbreaks, only few presented statistical prediction validity of EWS; (2) while entomological, epidemiological, and social media alarm indicators are potentially useful for outbreak warning, almost all studies focus primarily or exclusively on meteorological indicators, which tends to limit the prediction capacity; (3) no assessment of the integration of the EWS into a routine surveillance system could be found, and only few studies addressed the users' perspective of the tool; (4) almost all EWS tools require highly skilled users with advanced statistics; and (5) spatial prediction remains a limitation with no tool currently able to map high transmission areas at small spatial level. In view of the escalating infectious diseases as global threats, gaps and challenges are significantly present within the EWS applications. While some advanced EWS showed high prediction abilities, the scarcity of tool assessments in terms of integration into existing national surveillance systems as well as of the feasibility of transforming model outputs into local vector control or action plans tends to limit in most cases the support of countries in controlling disease outbreaks.

Sections du résumé

BACKGROUND
Early warning systems (EWSs) are of increasing importance in the context of outbreak-prone diseases such as chikungunya, dengue, malaria, yellow fever, and Zika. A scoping review has been undertaken for all 5 diseases to summarize existing evidence of EWS tools in terms of their structural and statistical designs, feasibility of integration and implementation into national surveillance programs, and the users' perspective of their applications.
METHODS
Data were extracted from Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Latin American and Caribbean Health Sciences Literature (LILACS), PubMed, Web of Science, and WHO Library Database (WHOLIS) databases until August 2019. Included were studies reporting on (a) experiences with existing EWS, including implemented tools; and (b) the development or implementation of EWS in a particular setting. No restrictions were applied regarding year of publication, language or geographical area.
FINDINGS
Through the first screening, 11,710 documents for dengue, 2,757 for Zika, 2,706 for chikungunya, 24,611 for malaria, and 4,963 for yellow fever were identified. After applying the selection criteria, a total of 37 studies were included in this review. Key findings were the following: (1) a large number of studies showed the quality performance of their prediction models but except for dengue outbreaks, only few presented statistical prediction validity of EWS; (2) while entomological, epidemiological, and social media alarm indicators are potentially useful for outbreak warning, almost all studies focus primarily or exclusively on meteorological indicators, which tends to limit the prediction capacity; (3) no assessment of the integration of the EWS into a routine surveillance system could be found, and only few studies addressed the users' perspective of the tool; (4) almost all EWS tools require highly skilled users with advanced statistics; and (5) spatial prediction remains a limitation with no tool currently able to map high transmission areas at small spatial level.
CONCLUSIONS
In view of the escalating infectious diseases as global threats, gaps and challenges are significantly present within the EWS applications. While some advanced EWS showed high prediction abilities, the scarcity of tool assessments in terms of integration into existing national surveillance systems as well as of the feasibility of transforming model outputs into local vector control or action plans tends to limit in most cases the support of countries in controlling disease outbreaks.

Identifiants

pubmed: 34529649
doi: 10.1371/journal.pntd.0009686
pii: PNTD-D-20-01781
pmc: PMC8445439
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009686

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2019 Apr 15;13(4):e0007298
pubmed: 30986218
PLoS One. 2018 May 4;13(5):e0196811
pubmed: 29727447
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
PLoS Negl Trop Dis. 2012;6(11):e1908
pubmed: 23209852
Microbes Infect. 2002 Jun;4(7):699-705
pubmed: 12067829
Exp Biol Med (Maywood). 2011 Aug;236(8):944-54
pubmed: 21737578
Am J Trop Med Hyg. 2014 Sep;91(3):598-610
pubmed: 24957546
Parasit Vectors. 2018 Apr 24;11(1):262
pubmed: 29690906
BMC Med. 2018 Aug 6;16(1):129
pubmed: 30078378
PLoS Negl Trop Dis. 2016 Sep 21;10(9):e0004916
pubmed: 27653786
PLoS Negl Trop Dis. 2017 Oct 16;11(10):e0005973
pubmed: 29036169
Environ Health. 2016 Mar 08;15 Suppl 1:28
pubmed: 26961903
BMC Public Health. 2013 Jun 24;13:607
pubmed: 23800243
PLoS Negl Trop Dis. 2015 May 28;9(5):e0003808
pubmed: 26020627
PLoS Negl Trop Dis. 2017 Sep 22;11(9):e0005961
pubmed: 28937986
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Int J Health Geogr. 2014 Dec 09;13:50
pubmed: 25487167
PLoS Negl Trop Dis. 2016 Feb 19;10(2):e0004473
pubmed: 26894570
PLoS Negl Trop Dis. 2016 Apr 29;10(4):e0004681
pubmed: 27128312
PLoS Negl Trop Dis. 2017 Mar 6;11(3):e0005354
pubmed: 28263988
PLoS One. 2016 Mar 31;11(3):e0152688
pubmed: 27031524
EBioMedicine. 2016 Jul;9:250-256
pubmed: 27344225
BMC Infect Dis. 2018 Apr 17;18(1):180
pubmed: 29665783
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
Malar J. 2017 Feb 23;16(1):89
pubmed: 28231803
PLoS One. 2014 Aug 29;9(8):e106144
pubmed: 25170873
PLoS One. 2017 Jan 6;12(1):e0165085
pubmed: 28060809
Am J Trop Med Hyg. 2011 Aug;85(2):257-64
pubmed: 21813844
Elife. 2016 Feb 24;5:
pubmed: 26910315
Sci Rep. 2018 Mar 15;8(1):4629
pubmed: 29545610
Lancet. 2016 Feb 20;387(10020):719-21
pubmed: 26876373
Int J Environ Health Res. 2008 Aug;18(4):253-65
pubmed: 18668414
Malar J. 2014 Aug 22;13:329
pubmed: 25149479
Malar J. 2006 Aug 01;5:66
pubmed: 16882349
Malar J. 2012 May 14;11:165
pubmed: 22583705
Stat Med. 2013 Feb 28;32(5):864-83
pubmed: 22927252
PLoS Negl Trop Dis. 2012;6(5):e1648
pubmed: 22629476
New Microbes New Infect. 2020 Mar 18;35:100663
pubmed: 32300479
Milbank Q. 2014 Mar;92(1):7-33
pubmed: 24597553
PLoS One. 2019 Feb 7;14(2):e0212003
pubmed: 30730979
J Biomed Inform. 2018 May;81:16-30
pubmed: 29496631
Sci Total Environ. 2006 Aug 31;367(2-3):631-40
pubmed: 16584757
EBioMedicine. 2016 May;7:267-77
pubmed: 27322480
Environ Health Perspect. 2016 Sep;124(9):1369-75
pubmed: 26662617
Malar J. 2017 Nov 21;16(1):472
pubmed: 29162098
Int J Environ Res Public Health. 2015 Jun 02;12(6):6333-51
pubmed: 26042370
Clin Microbiol Infect. 2019 Feb;25(2):142-146
pubmed: 30553031
MEDICC Rev. 2015 Apr;17(2):20-8
pubmed: 26027583
Nature. 2017 Oct 26;550(7677):515-518
pubmed: 29019978
BMC Infect Dis. 2017 Jul 10;17(1):480
pubmed: 28693483
Trop Biomed. 2012 Sep;29(3):339-48
pubmed: 23018496
Emerg Infect Dis. 2019 Jun;25(6):1041-1049
pubmed: 31107221
PLoS One. 2016 Jun 27;11(6):e0157971
pubmed: 27348752
Travel Med Infect Dis. 2020 Jul - Aug;36:101814
pubmed: 32619732
Lancet Infect Dis. 2014 Jul;14(7):619-26
pubmed: 24841859
Rheumatol Ther. 2018 Dec;5(2):317-326
pubmed: 30047016
Am J Public Health. 1999 Mar;89(3):374-8
pubmed: 10076488
Trends Parasitol. 2001 Sep;17(9):438-45
pubmed: 11530356
Wkly Epidemiol Rec. 2016 Jul 29;91(30):349-64
pubmed: 27476189

Auteurs

Laith Hussain-Alkhateeb (L)

Global Health, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Tatiana Rivera Ramírez (T)

Centre for Medicine and Society, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.

Axel Kroeger (A)

Centre for Medicine and Society, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.

Ernesto Gozzer (E)

Universidad Peruana Cayetano Heredia, Lima, Peru.

Silvia Runge-Ranzinger (S)

Centre for Medicine and Society, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH